就在几天前，王大哥还在为资金周转难题愁眉不展。原来，王大哥经营化肥已有10余年，2023年在禹城 农商银行30万元信贷资金的支持下，逐步发展壮大，目前已开设两个店面，并积累了众多老客户。近 日，夏收秋种即将开始，作为当地农资供应的关键节点，他计划进一步扩大经营范围，增设店面，但大 量囤积化肥、种子与农药，加上前期资金回笼缓慢，导致他的现金流瞬间吃紧。关键时刻，禹城农商银 行伦镇分理处客户经理在"千企万户大走访"活动中，了解到王大哥的经营困境与资金需求，基于对其过 往良好经营状况和信用记录的深入考察，客户经理为其增加授信70万元，让王大哥紧锁的眉头得以舒 展。 走进禹城市伦镇新创农资经营店内，一袋袋化肥、种子、农药码放得整整齐齐，前来采购的农户们穿梭 其间，络绎不绝。"我这农资经销已有10多年，是周边农户购买农资的'老据点'，这背后多亏了禹城农 商银行的资金支持！"负责人王峰一边擦拭着额头的汗水，一边指着堆满农资的仓库感慨道。 近年来，禹城农商银行重点聚焦粮食生产、高标准农田建设、农业机械化等关键领域，建立起 "支行 +村委+农户" 三级联络机制，借助 "整村授信""千企万户大走访""一村一座谈" 等多种方式， ...

截至2025年5月23日收盘，楚天龙（003040）报收于12.46元，较上周的12.67元下跌1.66%。本周，楚天 龙5月22日盘中最高价报13.08元。5月23日盘中最低价报12.43元。楚天龙当前最新总市值57.46亿元，在 通信设备板块市值排名51/87，在两市A股市值排名2536/5148。 本周关注点 问：你们行业本期整体业绩怎么样？你们跟其他公司比如何？答：2024 年本行业及上游安全芯片行业 主要厂商经营业绩在激烈的市场竞争中承受了一定的压力，总体表现为收入与净利润的波动。具体而 言，同行业主要厂商业绩表现不一，主要因为细分产品占比差异、境外业务占比不同、研发投入及市场 推广力度等期间费用存在一定差异。 问：行业以后的发展前景怎样？答：近年来随着 I 与大模型、国密算法、区块链、量子加密等技术的飞 速发展和数字中国建设的全面推进，公司所处行业正发生着深刻的变革。一是嵌入式安全产品作为数字 安全与数字化服务的载体，在数字经济发展过程中作用愈发重要；二是 I 与大模型技术深刻变革智能硬 件行业竞争格局；三是数字人民币试点稳步推进，智能合约与业务平台服务前景广阔。 公司公告汇总 楚天龙股份有限公司 ...

日前正式施行的《中华人民共和国民营经济促进法》设有"投资融资促进"专章，为促进民营企业可 持续发展提供了法治保障。优化民营企业投融资环境是促进我国民营经济持续、健康、高质量发展的重 要一环。 近年来，我国在优化民营企业投融资环境方面取得重大进展。较为突出的制度性突破是在2023年启 动民营经济促进法立法进程，并在浙江和广东等省份先行试点相关条例，今年通过该法并开始施行。同 时，最高人民法院设立知识产权法庭，服务于关键核心技术攻关和知识产权保护，以司法护航新质生产 力发展；各地政府和金融机构也陆续推出促进民营企业投融资环境的优化举措。2021年成立的北京证券 交易所内设创新层和基础层，主要服务创新型中小企业，截至今年1月份，北交所上市公司263家，超八 成为中小企业，近九成为民企。同年，深圳推出"首贷户"培育机制，已惠及超过40万首贷户。资本市场 的注册制改革极大缩短了科创板和创业板IPO审核周期，推动民营企业上市融资。供应链金融、银行间 市场的"科创票据"等金融工具创新，已帮助成千上万民企获得融资。浙江省的"贷款码"、广东省的采购 预付款保函替代保证金，以及重庆市的商业价值信用贷款等为民企降低贷款门槛，缓解融 ...

5月23日，省政府新闻办举办发布会，介绍"助企融资纾困、推动工业经济高质量发展"有关情况。 聚焦工业重点领域和薄弱环节，省工信厅构建"考核+奖补+贴息+担保+风险缓释"多层次融资支持政策 体系，实施七项产融对接促进措施，积极协调引导优势金融资源服务实体经济，助力工业经济高质量发 展。今年一季度，全省规上工业增加值同比增长9.9%，高于全国3.4个百分点。 聚焦聚力打好重点产业链群建设硬仗，省工信厅会同人行陕西省分行匹配24家银行机构为主办行和 参与行，面向34条工业领域重点产业链、1794户重点企业，创新产业链供应链金融产品和服务。2024 年，全省34条工业领域重点产业链贷款余额5161.1亿元，全年新增发放贷款3202亿元。今年一季度，全 省重点产业链贷款余额5563.22亿元，新增发放贷款1158.1亿元。 开展"十行千亿惠万企"融资专项行动，省工信厅联合金融机构推出"工信贷""专精特新贷"等创新型 金融产品，深入50个特色工业园区和156个双创基地的中小微企业上门送服务，每年新增专项信贷资金 不少于2000亿元。 省工信厅还出台省级中小微企业银行信贷风险补偿政策，建立"工信贷"白名单，对出现的不良贷款 ...

证券代码：600724 证券简称：宁波富达 公告编号：2025-022 宁波富达股份有限公司关于 选举职工董事及调整部分专门委员会 委员的公告 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 宁波富达股份有限公司（以下简称"公司"）于2025年5月20日召开职工大会选举第十一届董事会职工董 事。同日，召开第十一届十四次董事会，审议通过了《关于调整部分专门委员会委员的议案》，同意公 司对相关董事会专门委员会组成人员进行调整。 一、选举职工董事的情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600724 证券简称：宁波富达 公告编号：2025-023 根据《公司法》《公司章程》等有关规定，公司董事会由7名董事组成，其中职工董事1名，由公司职工 大会选举产生。公司于2025年5月20日召开职工大会，选举章庆祝先生（简历附后）为公司第十一届董 事会职工董事，任期至公司第十一届董事会任期届满之日止。 二、调整部分董事会专门委员会委员的情况 公司于2025年5月19日召开了2024年年度股东大会审 ...

当前，作为提升金融服务实体经济质效的重要抓手，供应链金融以产业协同为纽带，以数字技术为支 撑，成为兴产业、促转型、稳经济的关键力量。 中国人民银行、金融监管总局等六部门近日联合发布的《关于规范供应链金融业务引导供应链信息服务 机构更好服务中小企业融资有关事宜的通知》(以下简称《通知》)强调，正确把握供应链金融内涵与方 向，以支持产业链供应链优化升级为着力点，聚焦制造业等重点行业和关键领域，增强产业链供应链韧 性和竞争力。 "最近一段时间，财务公司明显对供应链金融给予了特别的关注。"一名财务公司从业人士告诉《金融时 报》记者，"不仅是票据承兑、贴现等传统业务，在模式创新与科技赋能方面，也都开始进行积极尝试 并收获可喜的进展。" 同时，一些财务公司纷纷开始扩招相关人员，除了非融资性保函、票据等信贷业务领域，还包括与数字 化规划相关的金融科技人才。 万向财务公司近日在供应链金融专题交流会上透露，已联袂万向区块链创新打造了供应链服务系统，并 积极探索跨境供应链金融服务新模式。 本质上，作为企业内部的金融机构，财务公司做好供应链金融就是要高效畅通资金在产业链供应链各环 节的循环流转，助力拓展信贷服务边界。 供应链金融主 ...

轰鸣的车间，机械手精准抓取零件组装成崭新设备；热闹的商业街，小餐馆飘出饭菜香，老板麻利地给 外卖骑手递上打包盒——这些鲜活的生产和交易场景，就是实体经济发展生动的写照。 实体经济是经济发展的根基，关乎就业民生与技术创新，从田间耕作到工厂生产，支撑着社会运转与国 家发展。 金融是国民经济的血脉。今年3月，国务院办公厅印发《关于做好金融"五篇大文章"的指导意见》指 出，"坚持金融服务实体经济的根本宗旨""提升金融服务能力，优化资金供给结构，切实加强对重大战 略、重点领域和薄弱环节的优质金融服务"。 如何更好地服务实体经济？当下，供应链金融在促进产业与金融的良性循环、助力金融资源精准流向实 体企业、缓解中小企业融资压力方面起到重要作用。 那么，信托公司是否可以开展供应链金融相关业务？信托公司开展了哪些实践？ 发挥独特优势 近日，中国人民银行联合金融监管总局、最高人民法院、国家发展改革委、商务部、市场监管总局共同 印发《关于规范供应链金融业务引导供应链信息服务机构更好服务中小企业融资有关事宜的通知》，旨 在强化供应链金融业务规范，提升金融服务实体经济质效。 在业内专家看来，除了为供应链上企业提供服务，供应链金融还将推 ...

Core Viewpoint - The company held its 2024 annual performance briefing, where it engaged with investors and addressed various inquiries regarding its business operations and future strategies [1] Group 1: Financial Performance - In 2024, the company achieved a revenue of 515 million yuan, a decrease of 6.55% compared to the previous year, primarily due to a decline in the food additive business and changes in the scope of consolidated financial statements [2] - The company reported a net profit decline, but the non-recurring net profit attributable to shareholders increased by 40.73% year-on-year [2][19] - For Q1 2025, the company recorded a revenue of 103 million yuan and a net loss of 22.72 million yuan, which represents a reduction in losses of 7.6% compared to the same period last year [18] Group 2: Research and Development - The company plans to invest 23.65 million yuan in R&D for 2024, accounting for 4.59% of total revenue, with a focus on downstream products of phosgene, pharmaceutical/agricultural intermediates, and electronic chemicals [2] - The company aims to enhance its market share in electronic chemicals, with revenues projected to grow from 18.53 million yuan in 2023 to 30.11 million yuan in 2024 [2] Group 3: Operational Strategies - The company is focusing on optimizing its product structure, expanding market reach, increasing R&D investment, and improving operational efficiency to enhance shareholder returns [8][10] - The management emphasizes the importance of solid business foundations and efficient operations as the basis for market value growth [10] Group 4: Business Direction and Challenges - The company is committed to its core business of fine chemical products, including paper chemicals, fluorescent whitening agents, and pharmaceutical/agricultural intermediates [20] - The company is facing challenges due to continuous losses over the past four years, but management is optimistic about improving profitability through various operational enhancements [19][12] Group 5: Corporate Governance and Shareholder Engagement - The company has a governance structure in place to ensure compliance with legal and regulatory requirements, and it is actively pursuing compensation for performance commitments related to a major shareholder [5][28] - The company has engaged with investors through a Q&A session, achieving a 100% response rate to inquiries, indicating a commitment to transparency and shareholder communication [1]

R&D Investment and Financial Performance - In 2024, the company plans to invest CNY 23.65 million in R&D, accounting for 4.59% of total revenue [2] - The company reported a revenue of CNY 515 million in 2024, a decrease of 6.55% compared to the previous year [3] - The net profit for Q1 2025 was CNY -22.72 million, a reduction in losses by 7.6% year-on-year [11] Market Strategy and Product Development - Future R&D will focus on downstream products of phosgene, pharmaceutical/agricultural intermediates, and electronic chemicals [2] - The company aims to increase its market share in electronic chemicals, with projected revenues of CNY 18.53 million in 2023 and CNY 30.11 million in 2024 [2] - The company is exploring new business growth points and optimizing asset structure to enhance competitiveness [6] Operational Challenges and Management Response - The company faced operational challenges due to a decline in the food additive business and changes in the consolidation scope from selling equity [3] - Management is implementing a "1+N" control strategy to reduce costs and improve efficiency, resulting in an increase in overall gross margin [3] - The company is actively pursuing legal action regarding performance compensation claims against a major shareholder [5] Corporate Governance and Future Outlook - The company has no current plans for stock issuance or major restructuring [12] - The management emphasizes the importance of solid business foundations and efficient operations for market value growth [6] - The company is committed to enhancing its governance structure and ensuring compliance with legal requirements [8] Industry Context and Competitive Landscape - The fine chemical industry is experiencing structural differentiation, with some sectors benefiting from high demand while others face cost pressures [13] - The company recognizes the importance of technological innovation and green transformation in navigating industry challenges [18]

Group 1: Financial Performance - In 2024, the revenue from the system device business increased by 85%, but installation and debugging costs accounted for over 25% of the revenue [4] - The revenue from the life sciences sector reached 5.68 billion yuan, with a growth rate of 28% [14] - The revenue from the water treatment and ultrapure water business grew by 20%, with a total revenue of 6.88 billion yuan [7] Group 2: Operational Efficiency - The inventory turnover days extended to 180 days due to increased stock of system devices [4] - The company aims to reduce work-in-progress inventory by 25% through digital twin technology optimization [4] - The company achieved a 5-fold increase in inspection efficiency by replacing manual visual inspection with AI visual detection [3] Group 3: Market Expansion and Strategy - In 2024, overseas revenue accounted for 38% of total revenue, amounting to 6.55 billion yuan [10] - The company plans to enhance market development efficiency through the release of industry solution white papers covering six major fields [5] - The life sciences sector's revenue share increased to 29%, with a focus on new product development in peptide synthesis [5] Group 4: Research and Development - The R&D investment intensity reached 9.8%, but the patent implementation rate was below 45% [9] - The company holds 66 domestic and 13 foreign authorized patents, with 74 domestic and 103 foreign patents in the application stage [9] - The company is focusing on developing new types of polyethylene glycol carriers to increase drug loading capacity by 20% [5] Group 5: Supply Chain and Risk Management - The company reported no supply chain security challenges, with most raw materials already localized [12] - The accounts receivable turnover days extended to 125 days, with 65% of accounts receivable from system device projects [10] - The company is exploring credit insurance to cover 80% of accounts receivable to improve cash flow [10]